Next Article in Journal
Overexpression of Banana ATG8f Modulates Drought Stress Resistance in Arabidopsis
Next Article in Special Issue
Polysaccharide-Based Systems for Targeted Stem Cell Differentiation and Bone Regeneration
Previous Article in Journal
Functional Group-Dependent Induction of Astrocytogenesis and Neurogenesis by Flavone Derivatives
Previous Article in Special Issue
Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models
Open AccessReview

A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought

Department of Clinical, Surgical, Diagnostic & Pediatric Sciences, University of Pavia, 27100 Pavia, Italy
Fondazione IRCCS Policlinico S. Matteo, Immunology & Transplantation Laboratory/Pediatric Oncohematology/Cell Factory, 27100 Pavia, Italy
Hepatology and Transplantation Laboratory, Department of Surgery, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
Divisions of Abdominal and Transplantation Surgery, Department of Surgery, Geneva University Hospitals, 1205 Geneva, Switzerland
General Surgery Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Author to whom correspondence should be addressed.
S.C. and A.P. share the first authorship.
Biomolecules 2019, 9(12), 813;
Received: 30 October 2019 / Revised: 25 November 2019 / Accepted: 28 November 2019 / Published: 2 December 2019
(This article belongs to the Special Issue New Targets and Strategies in Regenerative Medicine)
Allogeneic liver transplantation is still deemed the gold standard solution for end-stage organ failure; however, donor organ shortages have led to extended waiting lists for organ transplants. In order to overcome the lack of donors, the development of new therapeutic options is mandatory. In the last several years, organ bioengineering has been extensively explored to provide transplantable tissues or whole organs with the final goal of creating a three-dimensional growth microenvironment mimicking the native structure. It has been frequently reported that an extracellular matrix-based scaffold offers a structural support and important biological molecules that could help cellular proliferation during the recellularization process. The aim of the present review is to underline the recent developments in cell-on-scaffold technology for liver bioengineering, taking into account: (1) biological and synthetic scaffolds; (2) animal and human tissue decellularization; (3) scaffold recellularization; (4) 3D bioprinting; and (5) organoid technology. Future possible clinical applications in regenerative medicine for liver tissue engineering and for drug testing were underlined and dissected. View Full-Text
Keywords: scaffold; regenerative medicine; liver; extracellular matrix; liver bioengineering scaffold; regenerative medicine; liver; extracellular matrix; liver bioengineering
Show Figures

Figure 1

MDPI and ACS Style

Croce, S.; Peloso, A.; Zoro, T.; Avanzini, M.A.; Cobianchi, L. A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought. Biomolecules 2019, 9, 813.

AMA Style

Croce S, Peloso A, Zoro T, Avanzini MA, Cobianchi L. A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought. Biomolecules. 2019; 9(12):813.

Chicago/Turabian Style

Croce, Stefania; Peloso, Andrea; Zoro, Tamara; Avanzini, Maria A.; Cobianchi, Lorenzo. 2019. "A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought" Biomolecules 9, no. 12: 813.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop